Kraig Biocraft Laboratories (KBLB) Liabilities and Shareholders Equity (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $2.6 million for Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $2.6 million, up 70.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.8 million (down 8.15% YoY), and the FY2025 annual result was $2.6 million, up 70.43% from the prior year.
• Liabilities and Shareholders Equity came in at $2.6 million for Q4 2025 at Kraig Biocraft Laboratories, up from $2.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.4 million in Q2 2022 to a low of $1.3 million in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $3.1 million (2021), against an average of $3.1 million.
• Across the five-year window, Liabilities and Shareholders Equity surged 597.07% in 2021 and plunged 53.44% in 2024, its largest moves.
• Kraig Biocraft Laboratories' Liabilities and Shareholders Equity stood at $3.0 million in 2021, then jumped by 51.26% to $4.6 million in 2022, then decreased by 29.27% to $3.2 million in 2023, then sank by 53.44% to $1.5 million in 2024, then soared by 70.43% to $2.6 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $2.6 million (Q4 2025), $2.4 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.